Combination Therapy Shows Potential in Psoriasis, Obesity

• by Kathryn Wighton

• May 20, 2026

Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis

• by Jeffrey Crowley, Eingun James Song, Linda Stein-Gold, Paolo Gisondi, Christopher G. Bunick, Vishvas Garg, Emanuele Leoncini, Blair Kaplan, Richard Ta, Bang Truong, Dolly Sharma, Bruce Strober

• July 2, 2026

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.

• by Andrea Surnit

• May 5, 2026

• 4 min

Rapid Onset of Action and Quality-of-Life Improvements in Chinese Patients with Plaque Psoriasis Treated with Calcipotriol plus Betamethasone Dipropionate Aerosol Foam in a Randomized Phase 3 Trial

• by Lin Cai, Furen Zhang, Guoqiang Zhang, Yangfeng Ding, Yan Zhou, Shanshan Li, Juan Tao, Wei Yan, Rong Xiao, Bin Yang, Jianjun Qiao, Xiaoyong Man, Zaixing Wang, Adam El Mongy Jørgensen, Merle Kurvits, Jens Strodl Andersen, Jianzhong Zhang

• May 3, 2026